Ivy Natal Company

Ivy Natal develops a process to create human egg cells from skin samples as a treatment for most cases of infertility.

Investors

Industry: Reproductive Health & Contraception
Headquarters: San Francisco, California, United States
Founded Date: 01-01-2020
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Total Funding: $250,000
Last Funding Date: 2020-04-14
Last Funding Type: Seed
Visit Website
hello@ivynatal.com
https://twitter.com/ivynatal
Register and Claim Ownership